The DOI matches its Crossref record.
Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes
Abstract
Human tumors can constitutively express cytokines and growth factors, but the extent of this expression has not been investigated. Using 44 different probes to cytokines, growth factors, and their receptors, we tested 21 melanoma and 5 melanocyte cultures for RNA transcript expression by reverse transcriptase‐polymerase chain reaction. With 30 amplification cycles, expression of the cytokines interleukin (IL)‐1β, IL‐6, leukemia inhibitory factor (LIF), IL‐7, groα, IL‐8 and the p35 chain of IL‐12 was detected in more than 60% of melanomas. Concomitant receptors for IL‐6 and IL‐7 were also detected. IL‐1α, IL‐5, Rantes, IL‐10, interferon (IFN)‐β, tumor‐necrosis factor (TNF)‐α, G‐colony‐stimulating factor (CSF) and GM‐CSF were expressed at lower levels. Melanocytes showed greatly reduced cytokine RNA transcripts, and only groα was consistently detected. No expression of IL‐2, IL‐3, IL‐4, IL‐9, the p40 chain of IL‐12, IFN‐α or IFN‐γ RNA transcripts was detected in melanomas or melanocytes. The growth factors expressed by melanomas and, after further signal amplification, by melanocytes were transforming growth factor (TGF)‐α, epidermal growth factor (EGF), TGF‐β, endothelial‐cell growth factor (ECGF), basic‐fibroblast growth factor (bFGF), nerve growth factor (NGF) and steel. The receptors EGFR, FGFR, NGFRp70 and c‐kit were also expressed by melanomas and melanocytes. These results point to new possible autocrine and paracrine pathways in melanoma biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Munn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A., & Mellor, A. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21583 · Cited by 852
Interleukin-8 and human cancer biology
Xie, K. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00016-8 · Cited by 689
The Inflammatory Chemokine CCL5 and Cancer Progression
Aldinucci, D., & Colombatti, A. (2014) · Mediators of Inflammation · doi:10.1155/2014/292376 · Cited by 438
Immunotherapy of cancer in 2012
Kirkwood, J. M., Butterfield, L. H., Tarhini, A. A., Zarour, H., Kalinski, P., & Ferrone, S. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20132 · Cited by 436
AUTOCRINE AND PARACRINE REGULATION BY CYTOKINES AND GROWTH FACTORS IN MELANOMA
Lázár-Molnár, E., Hegyesi, H., Tóth, S., & Falus, A. (2000) · Cytokine · doi:10.1006/cyto.1999.0614 · Cited by 416
Immune Response in Stat2 Knockout Mice
Park, C., Li, S., Cha, E., & Schindler, C. (2000) · Immunity · doi:10.1016/s1074-7613(00)00077-7 · Cited by 415
A pivotal role for ERK in the oncogenic behaviour of malignant melanoma?
Smalley, K. S. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.10978 · Cited by 325
Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients
Parmiani, G., Castelli, C., Pilla, L., Santinami, M., Colombo, M. P., & Rivoltini, L. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl158 · Cited by 300
Self-citationIntegrin signaling in malignant melanoma
Kuphal, S., Bauer, R., & Bosserhoff, A.-K. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-1572-1 · Cited by 289
Hu, W.-P., Wang, J.-J., Yu, C.-L., Lan, C.-C. E., Chen, G.-S., & Yu, H.-S. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700826 · Cited by 258
Metadata
- Authors
- Mattei, S., Colombo, M. P., Melani, C., Silvani, A., Parmiani, G., & Herlyn, M.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1994-03-15
- Volume
- 56
- Issue
- 6
- Pages
- 853-857
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2041768004
- Cited by
- 235
- References
- 0
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.